Company: BIAF
Filing Date: 2025-05-27
Form Type: 8-K
Source: 0001641172-25-012411
Chunk: 2

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-27
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item
9.01. Financial Statements and Exhibits.

(d)
Exhibits

  Exhibit      Description                                                                                                       
   Number                                                                                                                        
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      1.1      At-The-Market Issuance Sales Agreement by and between bioAffinity Technologies, Inc. and WallachBeth Capital LLC  
      5.1      Opinion of Blank Rome, LLP regarding legality of shares of Common Stock                                           
     23.1      Consent of Blank Rome LLP (including in Exhibit 5.1)                                                              
      104      Cover                                                                                                             

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.

  Date:      May           BIOAFFINITY                                          
             27, 2025      TECHNOLOGIES, INC.                                   
 ────────────────────────────────────────────────────────────────────────────────
                           By:                     /s/                          
                           Name:                   Maria                        
                           Title:                  President